A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
about
Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies.Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
P2860
A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A potential use of a synthetic ...... of human stomach cancer cells.
@en
A potential use of a synthetic ...... of human stomach cancer cells.
@nl
type
label
A potential use of a synthetic ...... of human stomach cancer cells.
@en
A potential use of a synthetic ...... of human stomach cancer cells.
@nl
prefLabel
A potential use of a synthetic ...... of human stomach cancer cells.
@en
A potential use of a synthetic ...... of human stomach cancer cells.
@nl
P2093
P2860
P1476
A potential use of a synthetic ...... of human stomach cancer cells.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.2001.TB02144.X
P577
2001-11-01T00:00:00Z